UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment

The American journal of medicine, 2012, Vol.125 (1), p.S3-S13

Pfaller, Michael A., MD

2012

Volltextzugriff (PDF)

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008

PloS one, 2014-07, Vol.9 (7), p.e101510-e101510

2014

Volltextzugriff (PDF)

Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016

Open forum infectious diseases, 2019-03, Vol.6 (Supplement_1), p.S79-S94

2019

Volltextzugriff (PDF)

Epidemiology of Invasive Mycoses in North America

Critical reviews in microbiology, 2010-02, Vol.36 (1), p.1-53

2010

Volltextzugriff (PDF)

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

Journal of Clinical Microbiology, 2013-08, Vol.51 (8), p.2571-2581

2013

Volltextzugriff (PDF)

Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program

Open forum infectious diseases, 2019-03, Vol.6 (Supplement_1), p.S47-S53

2019

Volltextzugriff (PDF)

T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis

Future microbiology, 2016-01, Vol.11 (1), p.103-117

2016

Volltextzugriff (PDF)

Geographic Variations in Species Distribution and Echinocandin and Azole Antifungal Resistance Rates among Candida Bloodstream Infection Isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)

Journal of Clinical Microbiology, 2011-01, Vol.49 (1), p.396-399

2011

Volltextzugriff (PDF)

In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds

Journal of Clinical Microbiology, 2013-08, Vol.51 (8), p.2608-2616

2013

Volltextzugriff (PDF)

Candida guilliermondii and Other Species of Candida Misidentified as Candida famata: Assessment by Vitek 2, DNA Sequencing Analysis, and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry in Two Global Antifungal Surveillance Programs

Journal of Clinical Microbiology, 2013-01, Vol.51 (1), p.117-124

2013

Volltextzugriff (PDF)

Analysis of Candida auris fungemia at a single facility in Kenya

International journal of infectious diseases, 2019-08, Vol.85, p.182-187

2019

Volltextzugriff (PDF)

Geographic Distribution and Antifungal Susceptibility of the Newly Described Species Candida orthopsilosis and Candida metapsilosis in Comparison to the Closely Related Species Candida parapsilosis

Journal of Clinical Microbiology, 2008-08, Vol.46 (8), p.2659-2664

2008

Volltextzugriff (PDF)

Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008–2009)

Diagnostic microbiology and infectious disease, 2010-11, Vol.68 (3), p.278-283

2010

Volltextzugriff (PDF)

Trends in the susceptibility of U.S. Acinetobacter baumannii-calcoaceticus species complex and Stenotrophomonas maltophilia isolates to minocycline, 2014-2021

Microbiology spectrum, 2023-12, Vol.11 (6), p.e0198123-e0198123

2023

Volltextzugriff (PDF)

Use of Micafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 3,764 Clinical Isolates of Candida by Use of CLSI Methods and Interpretive Criteria

Journal of Clinical Microbiology, 2014-01, Vol.52 (1), p.108-114

2014

Volltextzugriff (PDF)

Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015–2018

International journal of infectious diseases, 2021-11, Vol.112, p.321-326

2021

Volltextzugriff (PDF)

Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases

Journal of Clinical Microbiology, 2005-05, Vol.43 (5), p.2155-2162

2005

Volltextzugriff (PDF)

Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific

Journal of fungi (Basel), 2023-02, Vol.9 (2), p.241

2023

Volltextzugriff (PDF)

Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)

The Brazilian journal of infectious diseases, 2017-11, Vol.21 (6), p.627-637

2017

Volltextzugriff (PDF)

Triazole and Echinocandin MIC Distributions with Epidemiological Cutoff Values for Differentiation of Wild-Type Strains from Non-Wild-Type Strains of Six Uncommon Species of Candida

Journal of Clinical Microbiology, 2011-11, Vol.49 (11), p.3800-3804

2011

Volltextzugriff (PDF)

Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans , and Aspergillus fumigatus : application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009)

Diagnostic microbiology and infectious disease, 2011, Vol.69 (1), p.45-50

2011

Volltextzugriff (PDF)

Identification of Candida nivariensis and Candida bracarensis in a Large Global Collection of Candida glabrata Isolates: Comparison to the Literature

Journal of Clinical Microbiology, 2009-04, Vol.47 (4), p.1216-1217

2009

Volltextzugriff (PDF)

In Vitro Activity of Isavuconazole and Other Mould-Active Azoles against Aspergillus fumigatus with and without CYP51 Alterations

Journal of fungi (Basel), 2023-05, Vol.9 (6), p.608

2023

Volltextzugriff (PDF)

Lodderomyces elongisporus Masquerading as Candida parapsilosis as a Cause of Bloodstream Infections

Journal of Clinical Microbiology, 2008-01, Vol.46 (1), p.374-376

2008

Volltextzugriff (PDF)

Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

Clinical Microbiology Reviews, 2001-10, Vol.14 (4), p.643-658

2001

Volltextzugriff (PDF)

1 – 25 von 574

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals 2020 Medicine

KollektioneBooks on EBSCOhost

ThemaPharmacology & Pharmacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(552)
Mit Volltextzugriff
(475)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(391)
Life Sciences & Biomedicine
(371)
Humans
(297)
Biological And Medical Sciences
(246)
Microbiology
(245)
Infectious Diseases
(222)
Medical Sciences
(182)
Fundamental And Applied Biological Sciences. Psychology
(131)
Microbial Sensitivity Tests
(113)
Pharmacology. Drug Treatments
(89)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(84)
Mycology
(81)
Antifungal Agents - Pharmacology
(76)
Antibacterial Agents
(59)
Bacteriology
(58)
Epidemiology
(58)
Anti-Bacterial Agents - Pharmacology
(57)
Male
(57)
Female
(55)
Candida - Drug Effects
(54)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008

Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016

Epidemiology of Invasive Mycoses in North America

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program

T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis

Geographic Variations in Species Distribution and Echinocandin and Azole Antifungal Resistance Rates among Candida Bloodstream Infection Isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)

In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds

Candida guilliermondii and Other Species of Candida Misidentified as Candida famata: Assessment by Vitek 2, DNA Sequencing Analysis, and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry in Two Global Antifungal Surveillance Programs

Analysis of Candida auris fungemia at a single facility in Kenya

Geographic Distribution and Antifungal Susceptibility of the Newly Described Species Candida orthopsilosis and Candida metapsilosis in Comparison to the Closely Related Species Candida parapsilosis

Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008–2009)

Trends in the susceptibility of U.S. Acinetobacter baumannii-calcoaceticus species complex and Stenotrophomonas maltophilia isolates to minocycline, 2014-2021

Use of Micafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 3,764 Clinical Isolates of Candida by Use of CLSI Methods and Interpretive Criteria

Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015–2018

Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases

Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific

Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)

Triazole and Echinocandin MIC Distributions with Epidemiological Cutoff Values for Differentiation of Wild-Type Strains from Non-Wild-Type Strains of Six Uncommon Species of Candida

Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans , and Aspergillus fumigatus : application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009)

Identification of Candida nivariensis and Candida bracarensis in a Large Global Collection of Candida glabrata Isolates: Comparison to the Literature

In Vitro Activity of Isavuconazole and Other Mould-Active Azoles against Aspergillus fumigatus with and without CYP51 Alterations

Lodderomyces elongisporus Masquerading as Candida parapsilosis as a Cause of Bloodstream Infections

Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

Aktive Filter

Suchergebnisse filtern